| 0.345 -0.017 (-4.7%) | 10-07 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.44 | 1-year : | 0.49 |
| Resists | First : | 0.38 | Second : | 0.42 |
| Pivot price | 0.36  |
|||
| Supports | First : | 0.31 | Second : | 0.25 |
| MAs | MA(5) : | 0.36 |
MA(20) : | 0.36 |
| MA(100) : | 0.52 |
MA(250) : | 0.71 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1  |
| %K %D | K(14,3) : | 41 |
D(3) : | 48.9 |
| RSI | RSI(14): 37.8 |
|||
| 52-week | High : | 1.64 | Low : | 0.31 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ DCGO ] has closed above bottom band by 19.2%. Bollinger Bands are 61.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 21 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.36 - 0.36 | 0.36 - 0.36 |
| Low: | 0.33 - 0.34 | 0.34 - 0.34 |
| Close: | 0.34 - 0.35 | 0.35 - 0.35 |
DocGo Inc. is a company dedicated to providing mobile healthcare solutions and medical transportation for a wide array of healthcare organizations in both the United States and the United Kingdom. Their transportation portfolio includes critical emergency response, alongside routine non-emergency transfers facilitated by ambulance and specialized wheelchair-accessible vehicles. Additionally, DocGo offers a range of mobile health services, delivered directly to patients' homes and offices through its advanced digital platform. These services further extend to include COVID-19 diagnostic testing and comprehensive on-site healthcare support for various events, such as large sporting competitions and concerts. The company was founded in 2015 and is headquartered in New York, New York.
Mon, 05 Oct 2026
New loan financing brings a warrant for up to 4M DocGo (DCGO) shares. - Stock Titan
Tue, 29 Sep 2026
DocGo Inc. (DCGO) Discusses Pending Acquisition of Hicuity Health and Related Financial Projections - Slideshow - Seeking Alpha
Sun, 27 Sep 2026
DocGo (DCGO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga España
Wed, 23 Sep 2026
DocGo Announces Upcoming Webinar to Outline Vision and Details of the Pending Hicuity Health Acquisition - Business Wire
Tue, 18 Aug 2026
DocGo Inc (DCGO) (Q2 2026) Earnings Call Highlights: Record Volumes and Strategic Hicuity ... - Yahoo Finance
Mon, 17 Aug 2026
DocGo Announces Second Quarter 2026 Results - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 99 (M) |
| Shares Float | 96 (M) |
| Held by Insiders | 3 (%) |
| Held by Institutions | 39 (%) |
| Shares Short | 2,220 (K) |
| Shares Short P.Month | 2,310 (K) |
| EPS | -1.95 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.2 |
| Profit Margin | -65.3 % |
| Operating Margin | -24.5 % |
| Return on Assets (ttm) | -19.9 % |
| Return on Equity (ttm) | -107.8 % |
| Qtrly Rev. Growth | -8.7 % |
| Gross Profit (p.s.) | 0.89 |
| Sales Per Share | 2.97 |
| EBITDA (p.s.) | -0.82 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -23 (M) |
| Levered Free Cash Flow | 2 (M) |
| PE Ratio | -0.18 |
| PEG Ratio | 0 |
| Price to Book value | 0.28 |
| Price to Sales | 0.11 |
| Price to Cash Flow | -1.51 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|